How we diagnose and treat vitreoretinal lymphoma.

  title={How we diagnose and treat vitreoretinal lymphoma.},
  author={Falko Fend and Andr{\'e}s J M Ferreri and Sarah E Coupland},
  journal={British journal of haematology},
  volume={173 5},
The eye is a rare site for the development of malignant lymphoma. Based on cell type and involved intraocular structures, which as a whole represent an immune-privileged site, several subtypes of primary intraocular lymphoma need to be discerned. Primary vitreoretinal lymphoma (PVRL), the most common form, is an aggressive B-cell malignancy and considered a subtype of primary central nervous system (CNS) lymphoma. Ocular symptoms are non-specific and often mimic uveitis, frequently resulting in… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 10 extracted citations


Publications referenced by this paper.
Showing 1-10 of 86 references

Intravitreal methotrexate

  • J. Pe’er
  • 2008
Highly Influential
4 Excerpts

Molecular pathology of primary intraocular lymphoma

  • C. C. Chan
  • Transactions of the American Ophthalmological…
  • 2003
Highly Influential
11 Excerpts

Molecular analysis of immunoglobulin genes in primary intraocular lymphoma

  • S. E. Coupland, M. Hummel, H. H. Muller, H. Stein
  • Investigative Ophthalmology & Visual Science,
  • 2005
Highly Influential
4 Excerpts

Genome-wide analysis

  • E. Braggio, S. Van Wier, +14 authors B. P. O’Neill
  • 2015
2 Excerpts

Similar Papers

Loading similar papers…